Measurements of medial temporal lobe atrophy for prediction of Alzheimer's disease in subjects with mild cognitive impairment

Neurobiology of Aging

Volumn 34, Issue 8, 2013, Pages 2003-2013

  Clerx, Lies ^a   van Rossum, Ineke A ^b   Burns, Leah ^c   Knol, Dirk L ^d   Scheltens, Philip ^b   Verhey, Frans ^a   Aalten, Pauline ^a   Lapuerta, Pablo ^e   Van de Pol, Laura ^b   Van Schijndel, Ronald ^b   De Jong, Remko ^b   Barkhof, Frederik ^b   Wolz, Robin ^f   Rueckert, Daniel ^f   Bocchetta, Martina ^g   Tsolaki, Magdalini ^h   Nobili, Flavio ⁱ   Wahlund, Lars Olaf ^j   Minthon, Lennart ^k   Frölich, Lutz ^l   Hampel, Harald ^m   Soininen, Hilkka ⁿ   Visser, Pieter Jelle ^a,b   more..

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c BRISTOL MYERS SQUIBB   (United States)

^d VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^e LEXICON PHARMACEUTICALS INC   (United States)

^f IMPERIAL COLLEGE LONDON   (United Kingdom)

^g IRCCS ISTITUTO CENTRO SAN GIOVANNI DI DIO FATEBENEFRATELLI   (Italy)

^h ARISTOTLE UNIVERSITY OF THESSALONIKI   (Greece)

ⁱ UNIVERSITY OF GENOA   (Italy)

^j KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^k LUND UNIVERSITY   (Sweden)

^l UNIVERSITY OF HEIDELBERG   (Germany)

^m GOETHE UNIVERSITY   (Germany)

ⁿ KUOPIO UNIVERSITY HOSPITAL   (Finland)

more..

Author keywords

A 1 42; Alzheimer's disease; Cerebrospinal fluid (CSF); Dementia; Magnetic resonance imaging; Medial temporal lobe atrophy; Mild cognitive impairment; Tau

Indexed keywords

AMYLOID BETA PROTEIN[1-42]; TAU PROTEIN;

AGED; ALZHEIMER DISEASE; ARTICLE; AUTOANALYSIS; BRAIN ATROPHY; BRAIN REGION; CEREBROSPINAL FLUID ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; FEMALE; HIPPOCAMPUS; HUMAN; INTERMETHOD COMPARISON; LATERAL BRAIN VENTRICLE; MAJOR CLINICAL STUDY; MALE; MEDIAL TEMPORAL LOBE; MILD COGNITIVE IMPAIRMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN PHOSPHORYLATION; TEMPORAL LOBE; VISUAL ANALOG SCALE;

AGED; ALZHEIMER DISEASE; AMYLOID BETA-PEPTIDES; ATROPHY; BIOLOGICAL MARKERS; COGNITION; DISEASE PROGRESSION; FEMALE; FORECASTING; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MILD COGNITIVE IMPAIRMENT; PEPTIDE FRAGMENTS; TAU PROTEINS;

EID: 84878132444     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2013.02.002     Document Type: Article

References (89)

1. Aljabar P., Heckemann R.A., Hammers A., Hajnal J.V., Rueckert D. Multi-atlas based segmentation of brain images: atlas selection and its effect on accuracy. Neuroimage 2009, 46:726-738.
2. American Psychiatric Association Diagnostic and Statistical Manual of Mental Disorders 1994, American Psychiatric Association, Washington, D.C. fourth ed.
3. Andreasen N., Hesse C., Davidsson P., Minthon L., Wallin A., Winblad B., Vanderstichele H., Vanmechelen E., Blennow K. Cerebrospinal fluid beta-amyloid(1-42) in Alzheimer disease: differences between early- and late-onset Alzheimer disease and stability during the course of disease. Arch. Neurol. 1999, 56:673-680.
4. Apostolova L.G., Dinov I.D., Dutton R.A., Hayashi K.M., Toga A.W., Cummings J.L., Thompson P.M. 3D comparison of hippocampal atrophy in amnestic mild cognitive impairment and Alzheimer's disease. Brain 2006, 129:2867-2873. [erratum in 2007;130:2474].
5. Apostolova L.G., Hwang K.S., Andrawis J.P., Green A.E., Babakchanian S., Morra J.H., Cummings J.L., Toga A.W., Trojanowski J.Q., Shaw L.M., Jack C.R., Petersen R.C., Aisen P.S., Jagust W.J., Koeppe R.A., Mathis C.A., Weiner M.W., Thompson P.M., Alzheimer's Disease Neuroimaging Initiative 3D PIB and CSF biomarker associations with hippocampal atrophy in ADNI subjects. Neurobiol. Aging 2010, 31:1284-1303.
6. Arlt, S., Buchert, R., Spies, L., Eichenlaub, M., Lehmbeck, J.T., Jahn, H., 2012. Association between fully automated MRI-based volumetry of different brain regions and neuropsychological test performance in patients with amnestic mild cognitive impairment and Alzheimer's disease. Eur. Arch. Psychiatry Clin. Neurosci.
7. Barnes J., Ourselin S., Fox N.C. Clinical application of measurement of hippocampal atrophy in degenerative dementias. Hippocampus 2009, 19:510-516.
8. Bartlett J.W., Frost C., Mattsson N., Skillbäck T., Blennow K., Zetterberg H., Schott J.M. Determining cut-points for Alzheimer's disease biomarkers: statistical issues, methods and challenges. Biomark. Med. 2012, 6:391-400.
9. Blennow K., Wallin A., ågren H., Spenger C., Siegfried J., Vanmechelen E. Tau protein in cerebrospinal fluid: a biochemical diagnostic marker for axonal degeneration in Alzheimer's disease?. Mol. Chem. Neuropathol. 1995, 26:231-245.
10. Boccardi M., Ganzola R., Bocchetta M., Pievani M., Redolfi A., Bartzokis G., Camicioli R., Csernansky J.G., de Leon M.J., deToledo-Morrell L., Killiany R.J., Lehéricy S., Pantel J., Pruessner J.C., Soininen H., Watson C., Duchesne S., Jack C.R., Frisoni G.B. Survey of protocols for the manual segmentation of the hippocampus: preparatory steps towards a joint EADC-ADNI harmonized protocol. J. Alzheimers Dis. 2011, 26(suppl. 3):61-75.
11. Burgmans S., van Boxtel M.P., Smeets F., Vuurman E.F., Gronenschild E.H., Verhey F.R., Uylings H.B., Jolles J. Prefrontal cortex atrophy predicts dementia over a six-year period. Neurobiol. Aging 2009, 30:1413-1419.
12. Callen D.J., Black S.E., Gao F., Caldwell C.B., Szalai J.P. Beyond the hippocampus: MRI volumetry confirms widespread limbic atrophy in AD. Neurology 2001, 57:1669-1674.
13. Carmichael O., Xie J., Fletcher E., Singh B., DeCarli C. Localized hippocampus measures are associated with Alzheimer pathology and cognition independent of total hippocampal volume. Neurobiol. Aging 2012, 33:1124.e1131-1124.e1141.
14. Carmichael O.T., Aizenstein H.A., Davis S.W., Becker J.T., Thompson P.M., Meltzer C.C., Liu Y. Atlas-based hippocampus segmentation in Alzheimer's disease and mild cognitive impairment. Neuroimage 2005, 27:979-990.
15. Chen T.F., Lin C.C., Chen Y.F., Liu H.M., Hua M.S., Huang Y.C., Chiu M.J. Diffusion tensor changes in patients with amnesic mild cognitive impairment and various dementias. Psychiatry Res. 2009, 173:15-21.
16. Chincarini A., Bosco P., Calvini P., Gemme G., Esposito M., Olivieri C., Rei L., Squarcia S., Rodriguez G., Bellotti R., Cerello P., De Mitri I., Retico A., Nobili F., Alzheimer's Disease Neuroimaging Initiative Local MRI analysis approach in the diagnosis of early and prodromal Alzheimer's disease. Neuroimage 2011, 58:469-480.
17. Choo I.L., Lee D.Y., Oh J.S., Lee J.S., Lee D.S., Song I.C., Youn J.C., Kim S.G., Kim K.W., Jhoo J.H., Woo J.I. Posterior cingulate cortex atrophy and regional cingulum disruption in mild cognitive impairment and Alzheimer's disease. Neurobiol. Aging 2010, 31:772-779.
18. Chou Y.Y., Lepore N., Saharan P., Madsen S.K., Hua X., Jack C.R., Shaw L.M., Trojanowski J.Q., Weiner M.W., Toga A.W., Thompson P.M., Alzheimer's Disease Neuroimaging Initiative Ventricular maps in 804 ADNI subjects: correlations with CSF biomarkers and clinical decline. Neurobiol. Aging 2010, 31:1386-1400.
19. Chupin M., Gérardin E., Cuingnet R., Boutet C., Lemieux L., Lehéricy S., Benali H., Garnero L., Colliot O., Alzheimer's Disease Neuroimaging Initiative Fully automatic hippocampus segmentation and classification in Alzheimer's disease and mild cognitive impairment applied on data from ADNI. Hippocampus 2009, 19:579-587.
20. Colliot O., Chételat G., Chupin M., Desgranges B., Magnin B., Benali H., Dubois B., Garnero L., Eustache F., Lehéricy S. Discrimination between Alzheimer disease, mild cognitive impairment, and normal aging by using automated segmentation of the hippocampus. Radiology 2008, 248:194-201.
21. Csernansky J.G., Hamstra J., Wang L., McKeel D., Price J.L., Gado M., Morris J.C. Correlations between antemortem hippocampal volume and postmortem neuropathology in AD subjects. Alzheimer Dis. Assoc. Disord. 2004, 18:190-195.
22. DeCarli C., Frisoni G.B., Clark C.M., Harvey D., Grundman M., Petersen R.C., Thal L.J., Jin S., Jack C.R., Scheltens P. Qualitative estimates of medial temporal atrophy as a predictor of progression from mild cognitive impairment to dementia. Arch. Neurol. 2007, 64:108-115. Alzheimer's Disease Cooperative Study Group.
23. DeCarli C.M., Kaye J.A., Horwitz B.P., Rapoport S.I. Critical analysis of the use of computer-assisted transverse axial tomography to study human brain in aging and dementia of the Alzheimer type. Neurology 1990, 40:872-883.
24. de Souza L.C., Chupin M., Lamari F., Jardel C., Leclercq D., Colliot O., Lehéricy S., Dubois B., Sarazin M. CSF tau markers are correlated with hippocampal volume in Alzheimer's disease. Neurobiol. Aging 2012, 33:1253-1257.
25. Di Paola M., Di Iulio F., Cherubini A., Blundo C., Casini A.R., Sancesario G., Passafiume D., Caltagirone C., Spalletta G. When, where, and how the corpus callosum changes in MCI and AD: a multimodal MRI study. Neurology 2010, 74:1136-1142.
26. Echávarri C., Aalten P., Uylings H.B., Jacobs H., Visser P., Gronenschild E., Verhey F.R., Burgmans S. Atrophy in the parahippocampal gyrus as an early biomarker of Alzheimer's disease. Brain Struct. Funct. 2011, 215:265-271.
27. Frisoni G.B., Jack C.R. Harmonization of magnetic resonance-based manual hippocampal segmentation: a mandatory step for wide clinical use. Alzheimers Dement. 2011, 7:171-174.
28. Galton C.J., Gomez-Anson B., Antoun N., Scheltens P., Patterson K., Graves M., Sahakian B.J., Hodges J.R. Temporal lobe rating scale: application to Alzheimer's disease and frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 2001, 70:165-173.
29. Hanley J.A., McNeil B.J. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 1983, 148:839-843.
30. Heagerty P.J., Lumley T., Pepe M.S. Time-dependent ROC curves for censored survival data and a diagnostic marker. Biometrics 2000, 56:337-344.
31. Henneman W.J., Sluimer J.D., Cordonnier C., Baak M.M., Scheltens P., Barkhof F., van der Flier W.M. MRI biomarkers of vascular damage and atrophy predicting mortality in a memory clinic population. Stroke 2009, 40:492-498.
32. Hsu Y.Y., Schuff N., Du A.T., Mark K., Zhu X., Hardin D., Weiner M.W. Comparison of automated and manual MRI volumetry of hippocampus in normal aging and dementia. J. Magn. Reson. Imaging 2002, 16:305-310.
33. Jack C.R. MRI-based hippocampal volume measurements in epilepsy. Epilepsia 1994, 35:S21-S29.
34. Jack C.R., Dickson D.W., Parisi J.E., Xu Y.C., Cha R.H., O'Brien P.C., Edland S.D., Smith G.E., Boeve B.F., Tangalos E.G., Kokmen E., Petersen R.C. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia. Neurology 2002, 58:750-757.
35. Jack C.R., Shiung M.M., Gunter J.L., O'Brien P.C., Weigand S.D., Knopman D.S., Boeve B.F., Ivnik R.J., Smith G.E., Cha R.H., Tangalos E.G., Petersen R.C. Comparison of different MRI brain atrophy rate measures with clinical disease progression in AD. Neurology 2004, 62:591-600.
36. Jacobs H.I., Van Boxtel M.P., Jolles J., Verhey F.R., Uylings H.B. Parietal cortex matters in Alzheimer's disease: an overview of structural, functional and metabolic findings. Neurosci. Biobehav. Rev. 2012, 36:297-309.
37. Jenkinson M., Bannister P., Brady M., Smith S. Improved optimization for the robust and accurate linear registration and motion correction of brain images. Neuroimage 2002, 17:825-841.
38. Jenkinson M., Smith S. A global optimisation method for robust affine registration of brain images. Med. Image Anal. 2001, 5:143-156.
39. Jones B.F., Barnes J., Uylings H.B., Fox N.C., Frost C., Witter M.P., Scheltens P. Differential regional atrophy of the cingulate gyrus in Alzheimer disease: a volumetric MRI study. Cereb. Cortex 2006, 16:1701-1708.
40. Kolen M.J., Brennan R.L. Test Equating: Methods and Practices 1995, Springer, New York.
41. Laakso M.P., Soininen H., Partanen K., Helkala E., Hartikainen P., Vaino P., Hallikainen M., Hänninen T., Riekkinen P.J. Volumes of hippocampus, amygdala and frontal lobes in the MRI-based diagnosis of early Alzheimer's disease: correlation with memory functions. J. Neural Transm. Park. Dis. Dement. Sect. 1995, 9:73-86.
42. Lehmann M., Douiri A., Kim L.G., Modat M., Chan D., Ourselin S., Barnes J., Fox N.C. Atrophy patterns in Alzheimer's disease and semantic dementia: a comparison of FreeSurfer and manual volumetric measurements. Neuroimage 2010, 49:2264-2274.
43. Levy-Cooperman N., Ramirez J., Lobaugh N.J., Black S.E. Misclassified tissue volumes in Alzheimer disease patients with white matter hyperintensities. Stroke 2008, 39:1134-1141.
44. Lötjönen J., Wolz R., Koikkalainen J., Julkunen V., Thurfjell L., Lundqvist R., Waldemar G., Soininen H., Rueckert D., Alzheimer's Disease Neuroimaging Initiative Fast and robust extraction of hippocampus from MR images for diagnostics of Alzheimer's disease. Neuroimage 2011, 56:185-196.
45. Masters C.L., Beyreuther K. Alzheimer's centennial legacy: prospects for rational therapeutic intervention targeting the Abeta amyloid pathway. Brain 2006, 129:2823-2839.
46. McHugh T.L., Saykin A.J., Wishart H.A., Flashman L.A., Cleavinger H.B., Rabin L.A., Mamourian A.C., Shen L. Hippocampal volume and shape analysis in an older adult population. Clin. Neuropsychol. 2007, 21:130-145.
47. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
48. Morris J.C. The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993, 43:2412-2414.
49. Mulder C., Verwey N.A., van der Flier W.M., Bouwman F.H., Kok A., van Elk E.J., Scheltens P., Blankenstein M.A. Amyloid-β(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. Clin. Chem. 2010, 56:248-253.
50. Nestor S.M., Rupsingh R., Borrie M., Smith M., Accomazzi V., Wells J.L., Fogarty J., Bartha R., Alzheimer's Disease Neuroimaging Initiative Ventricular enlargement as a possible measure of Alzheimer's disease progression validated using the Alzheimer's disease neuroimaging initiative database. Brain 2008, 131:2443-2454.
51. Petersen R.C. Mild cognitive impairment as a diagnostic entity. J. Int. Med. 2004, 256:183-194.
52. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol. 1999, 56:303-308.
53. Ridha B.H., Barnes J., van de Pol L.A., Schott J.M., Boyes R.G., Siddique M.M., Rossor M.N., Scheltens P., Fox N.C. Application of automated medial temporal lobe atrophy scale to Alzheimer disease. Arch. Neurol. 2007, 64:849-854.
54. Risacher S.L., Saykin A.J., West J.D., Shen L., Firpi H.A., McDonald B.C., Alzheimers Disease Neuroimaging Initiative (ADNI) Baseline MRI predictors of conversion from MCI to probable AD in the ADNI cohort. Curr. Alzheimer Res. 2009, 6:347-361.
55. Rusinek H.P., Endo Y.M., De Santi S.P., Frid D.B., Tsui W.H., Segal S.M., Convit A., de Leon M.J. Atrophy rate in medial temporal lobe during progression of Alzheimer disease. Neurology 2004, 63:2354-2359.
56. Sanchez-Benavides G., Gomez-Anson B., Molinuevo J.L., Blesa R., Monte G.C., Buschke H., Peña-Casanova J. Medial temporal lobe correlates of memory screening measures in normal aging, MCI, and AD. J. Geriatr. Psychiatry Neurol. 2010, 23:100-108.
57. Sanchez-Benavides G., Gomez-Ansun B., Sainz A., Vives Y., Delfino M., Peoa-Casanova J. Manual validation of FreeSurfer's automated hippocampal segmentation in normal aging, mild cognitive impairment, and Alzheimer disease subjects. Psychiatry Res. 2010, 181:219-225.
58. Scheltens P., Leys D., Barkhof F., Huglo D., Weinstein H.C., Vermersch P., Kuiper M., Steinling M., Wolters E.C., Valk J. Atrophy of medial temporal lobes on MRI in " probable" Alzheimer's disease and normal ageing: diagnostic value and neuropsychological correlates. J. Neurol. Neurosurg. Psychiatry 1992, 55:967-972.
59. Schoonenboom N.S., van der Flier W.M., Blankenstein M.A., Bouwman F.H., Van Kamp G.J., Barkhof F., Scheltens P. CSF and MRI markers independently contribute to the diagnosis of Alzheimer's disease. Neurobiol. Aging 2008, 29:669-675.
60. Serra L., Cercignani M., Lenzi D., Perri R., Fadda L., Caltagirone C., Macaluso E., Bozzali M. Grey and white matter changes at different stages of Alzheimer's disease. J. Alzheimers Dis. 2010, 19:147-159.
61. Shen L., Saykin A., Kim S., Firpi H., West J., Risacher S., McDonald B.C., McHugh T.L., Wishart H.A., Flashman L.A. Comparison of manual and automated determination of hippocampal volumes in MCI and early AD. Brain Imaging Behav. 2010, 4:86-95.
62. Sluimer J.D., van der Flier W.M., Karas G.B., Fox N.C., Scheltens P., Barkhof F., Vrenken H. Whole-brain atrophy rate and cognitive decline: longitudinal MR study of memory clinic patients. Radiology 2008, 248:590-598.
63. Smith S.M. Fast robust automated brain extraction. Hum. Brain Mapp. 2002, 17:143-155.
64. Smith S.M., De Stefano N., Jenkinson M., Matthews P.M. Normalized accurate measurement of longitudinal brain change. J. Comp. Assist. Tomogr. 2001, 25:466-475.
65. Smith S.M., Jenkinson M., Woolrich M.W., Beckmann C.F., Behrens T.E., Johansen-Berg H., Bannister P.R., De Luca M., Drobnjak I., Flitney D.E., Niazy R.K., Saunders J., Vickers J., Zhang Y., De Stefano N., Brady J.M., Matthews P.M. Advances in functional and structural MR image analysis and implementation as FSL. Neuroimage 2004, 23:S208-S219.
66. Smith S.M., Zhang Y., Jenkinson M., Chen J., Matthews P.M., Federico A., De Stefano N. Accurate, robust, and automated longitudinal and cross-sectional brain change analysis. Neuroimage 2002, 17:479-489.
67. Tondelli M., Wilcock G.K., Nichelli P., De Jager C.A., Jenkinson M., Zamboni G. Structural MRI changes detectable up to ten years before clinical Alzheimer's disease. Neurobiol. Aging 2012, 33:825.e825-825.e836.
68. Urs R., Potter E., Barker W., Appel J., Loewenstein D.A., Zhao W., Duara R. Visual rating system for assessing magnetic resonance images: a tool in the diagnosis of mild cognitive impairment and Alzheimer disease. J. Comput. Assist. Tomogr. 2009, 33:73-78.
69. van de Pol L.A., Barnes J., Scahill R.I., Frost C., Lewis E.B., Boyes R.G., van Schijndel R.A., Scheltens P., Fox N.C., Barkhof F. Improved reliability of hippocampal atrophy rate measurement in mild cognitive impairment using fluid registration. Neuroimage 2007, 34:1036-1041.
70. van de Pol L.A., van der Flier W.M., Korf E.S., Fox N.C., Barkhof F., Scheltens P. Baseline predictors of rates of hippocampal atrophy in mild cognitive impairment. Neurology 2007, 69:1491-1497.
71. van de Pol L.A., Verhey F., Frisoni G.B., Tsolaki M., Papapostolou P., Nobili F., Wahlund L.O., Minthon L., Frölich L., Hampel H., Soininen H., Knol D.L., Barkhof F., Scheltens P., Visser P.J. White matter hyperintensities and medial temporal lobe atrophy in clinical subtypes of mild cognitive impairment: the DESCRIPA study. J. Neurol. Neurosurg. Psychiatry 2009, 80:1069-1074.
72. van Rossum I.A., Vos S.J., Burns L., Knol D.L., Scheltens P., Soininen H., Wahlund L.O., Hampel H., Tsolaki M., Minthon L., L'italien G., van der Flier W.M., Teunissen C.E., Blennow K., Barkhof F., Rueckert D., Wolz R., Verhey F., Visser P.J. Injury markers predict time to dementia in subjects with MCI and amyloid pathology. Neurology 2012, 79:1801-1816.
73. Varela-Nallar L., Aranguiz F.C., Abbott A.C., Slater P.G., Inestrosa N.C. Adult hippocampal neurogenesis in aging and Alzheimer's disease. Birth Defects Res. C Embryo Today 2010, 90:284-296.
74. Vellas B., Andrieu S., Sampaio C., Wilcock G. Disease-modifying trials in Alzheimer's disease: a European task force consensus. Lancet Neurol. 2007, 6:56-62.
75. Visser P.J., Scheltens P., Verhey F.R., Schmand B., Launer L., Jolles J., Jonker C. Medial temporal lobe atrophy and memory dysfunction as predictors for dementia in subjects with mild cognitive impairment. J. Neurol. 1999, 246:477-485.
76. Visser P.J., Verhey F., Knol D.L., Scheltens P., Wahlund L.O., Freund-Levi Y., Tsolaki M., Minthon L., Wallin A.K., Hampel H., Bürger K., Pirttila T., Soininen H., Rikkert M.O., Verbeek M.M., Spiru L., Blennow K. Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. Lancet Neurol. 2009, 8:619-627.
77. Visser P.J., Verhey F.R., Boada M., Bullock R., De Deyn P.P., Frisoni G.B., Frolich L., Hampel H., Jolles J., Jones R., Minthon L., Nobili F., Olde Rikkert M., Ousset P.J., Rigaud A.S., Scheltens P., Soininen H., Spiru L., Touchon J., Tsolaki M., Vellas B., Wahlund L.O., Wilcock G., Winblad B. Development of screening guidelines and clinical criteria for predementia Alzheimer's disease. Neuroepidemiology 2008, 30:254-265.
78. Visser P.J., Verhey F.R., Hofman P.A., Jolles J. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J. Neurol. Neurosurg. Psychiatry 2002, 72:491-497.
79. Visser P.J., Verhey F.R., Hofman P.A., Scheltens P., Jolles J. Medial temporal lobe atrophy predicts Alzheimer's disease in patients with minor cognitive impairment. J. Neurol. Neurosurg. Psychiatry 2002, 72:491-497.
80. Vos S., van Rossum I., Burns L., Knol D., Scheltens P., Soininen H., Wahlund L.O., Hampel H., Tsolaki M., Minthon L., Handels R., L'Italien G., van der Flier W., Aalten P., Teunissen C., Barkhof F., Blennow K., Wolz R., Rueckert D., Verhey F., Visser P.J. Test sequence of CSF and MRI biomarkers for prediction of AD in subjects with MCI. Neurobiol. Aging 2012, 33:2272-2281.
81. Wahlund L.O., Blennow K. Cerebrospinal fluid biomarkers for disease stage and intensity in cognitively impaired patients. Neurosci. Lett. 2003, 339:99-102.
82. Wahlund L.O., Julin P., Johansson S.E., Scheltens P. Visual rating and volumetry of the medial temporal lobe on magnetic resonance imaging in dementia: a comparative study. J. Neurol. Neurosurg. Psychiatry 2000, 69:630-635.
83. Wahlund L.O., Julin P., Lindqvist J., Scheltens P. Visual assessment of medial temporal lobe atrophy in demented and healthy control subjects: correlation with volumetry. Psychiatry Res. 1999, 90:193-199.
84. Wang H., Su M.Y. Regional pattern of increased water diffusivity in hippocampus and corpus callosum in mild cognitive impairment. Dement. Geriatr. Cogn. Disord. 2006, 22:223-229.
85. Westman E., Cavallin L., Muehlboeck J.S., Zhang Y., Mecocci P., Vellas B., Tsolaki M., Kłoszewska I., Soininen H., Spenger C., Lovestone S., Simmons A., Wahlund L.O. Sensitivity and specificity of medial temporal lobe visual ratings and multivariate regional MRI classification in Alzheimer's disease. PLoS One 2011, 6:e22506. AddNeuroMed consortium.
86. Wolz R., Aljabar P., Hajnal J.V., Hammers A., Rueckert D. LEAP: Learning embeddings for atlas propagation. Neuroimage 2010, 49:1316-1325.
87. Wolz R., Heckemann R.A., Aljabar P., Hajnal J.V., Hammers A., Lötjönen J., Rueckert D., Alzheimer's Disease Neuroimaging Initiative Measurement of hippocampal atrophy using 4D graph-cut segmentation: application to ADNI. Neuroimage 2010, 52:109-118.
88. Yavuz B.B., Ariogul S., Cankurtaran M., Oguz K.K., Halil M., Dagli N., Cankurtaran E.S. Hippocampal atrophy correlates with the severity of cognitive decline. Int. Psychogeriatr. 2007, 19:767-777.
89. Zhang Y., Brady M., Smith S. Segmentation of brain MR images through a hidden Markov random field model and the expectation-maximization algorithm. IEEE Trans. Med. Imaging 2001, 20:45-57.